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198 Time and handling of the I-Neb in target inhalation mode (TIM)
and tidal breathing mode (TBM) assessed in mild to severe
CF patients
S. Haeussermann1, J. Healy1, J. Edelman2. 1Inamed GmbH, Respiratory Research,
Gauting, Germany; 2CSL Behring, King of Prussia, United States
Objectives: For effective treatment of CF with inhaled drugs, efﬁcient, easy to use
devices are needed. This study was designed to assess time and practicability of
Alpha-1-Antitrypsin (A1-PI(H)), (77mg/1.1ml) lung deposition in CF patients.
Methods: Using the Respironics I-Neb AAD System. 15 mild to severe CF patients
(FEV1: 34–101%) were included to inhale study drug in two inhalation modes:
Target Inhalation Mode (TIM) and Tidal Breathing Mode (TBM).
Conclusion: Total inhalation time was lower in TIM (3±0.5 min) than in TBM
(4.5±2.1 min). Inhalation time and volume inhaled per breath were lower in TBM
than in TIM. Subjects inhaled more deeply and slowly in TIM. Consequently,
treatment time was longer and the number of breaths needed to deliver a similar dose
was higher in TBM than in TIM. In both inhalation modes a high percentage of CF
subjects rated their mouthpiece exhalation as “easy” and “very easy” (TIM: 80%,
TBM: 100%). In total, 87% of the CF subjects classiﬁed their mouthpiece inhalation
through in TBM as “easy” and “very easy” (TIM: 40%). For both inhalation modes
a high percentage of CF subjects classiﬁed the use of the I-neb as “easy” and “very
easy” (TIM: 71.5%, TBM: 86.7%).
All CF patients were able to inhale the full dose in <6min in TIM and <10min
in TBM. TIM is consistently more efﬁcient and less time consuming than TBM,
as reﬂected in total treatment and inhalation time, and number of breaths. All
CF patients could handle the device properly and most of them rated its use as easy
or very easy.
199 Early predictors of bronchiectasis and trapped air severity in
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Objective: Bronchiectasis (BE) and trapped air (TA), detected by chest computed
tomography (CT) are important determinants of cystic ﬁbrosis (CF) lung disease.
We aimed to identify early predictors of BE and TA severity in children with CF.
Methods: Single center longitudinal study. Inclusion: CF patients with two routine
bi-annual volumetric CTs, at least 5 years apart, aged 6−13 years at CT1. CTs
were anonymized and scored with CF-CT scoring system (% maximum score).
Predictors tested in univariate models are: socio economic status, FEV1 at CT1,
Pseudomonas ever before CT1, pulmonary exacerbations (iv antibiotic courses in
year prior to CT1), BE and TA scores at CT1. Stepwise multivariate modeling was
used to identify independent predictors.
Results: Twenty-seven patients were studied, median age 9.2 (6.9–12.9) years,
median time interval between CTs 6.5 (5.8−7.9) years. Children with Pseudomonas
ever had 7.91 (95% conﬁdence interval 2.26–13.58) % higher BE score at CT2
(p< 0.01). An exacerbation prior to CT1 resulted in a 22.4 (1.64–43.2) % higher
TA score at CT2 (p = 0.04). A 1% increase on BE score at CT1 resulted in a 1.04
(0.67–1.41) % higher BE score at CT2 (p< 0.01). A 1% increase on TA score at CT1
resulted in a 1.57 (0.06–3.08) % higher TA score at CT2 (p = 0.04). Multivariate
analysis showed that the BE score on CT1 remained predictive for BE (p< 0.01)
and TA (p = 0.04) at CT2.
Conclusion: Pseudomonas or exacerbation prior to CT1 predicted BE and TA at
CT2 (median) 6.5 years later. This effect appeared to be mediated through BE at
CT1, which was predictive of BE and TA severity 6.5 years later.
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200 Is sweat chloride predictive for severity of cystic ﬁbrosis (CF)
lung disease assessed by chest computed tomography (CT)?
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Background: CF lung disease is characterized by poor genotype–phenotype cor-
relation. Sweat chloride level is a functional marker of the CF Transmembrane
Regulator protein and could be a predictor of the severity of CF lung disease.
Objective: To study correlations between sweat chloride and bronchiectasis (BE),
trapped air (TA) and mucus plugging on chest CT.
Methods: Retrospective analysis. Inclusion: Availability of sweat chloride at time
of diagnosis and of at least one routine in- and expiratory spirometry-controlled
volumetric chest CT scan. CT scans were de-identiﬁed and randomized (Myrian®
Montpelier, Fr) and scored using the CF-CT scoring system (%max). Intra- and
interobserver variability: intraclass correlation coefﬁcient. Associations between
sweat chloride-levels and CF-CT subscores: Pearson’s correlation coefﬁcient and
multivariate regression models. Effect modiﬁcation age CT-scan tested by stratiﬁ-
cation. Descriptives: expressed as median (range).
Results: 69 Children (34 male), age sweat chloride 0.8 (0–19.5) years, age chest CT
13.8 (5.5−19) years, TA score 6.5 (0–25.5) %max and BE score 2 (0–24.3) %max.
Univariate analysis CF-CT scores vs sweat chloride (ns). Multivariate models
adjusting for age of sweat test and CT scan: signiﬁcant association between sweat
chloride and CF-CT BE (p = 0.036) and mucus plugging (p = 0.027). Stratiﬁcation
in tertiles for age of CT scan showed that association was present only in the oldest
age group (range 15−19 years).
Conclusion: Sweat chloride levels are predictive of long term CF lung disease as
determined by chest CT, the association was primarily determined by children older
than 15 years.
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Objectives: To describe the HRCT ﬁndings in patients with CF diagnosed in
adulthood and to correlate them with clinical and functional data; to describe
usefulness of additional pancreas CT study.
Methods: We reviewed the HRCT at the time of diagnosis of 52 patients (range
18−72 years) with CF diagnosed in adulthood. We analysed the pulmonary ﬁndings
according to the Brody scoring system, considering presence, severity and sym-
metry and distribution of bronchiectasis, mucous plugs, bronchial wall thickening,
bubbles, emphysema, atelectasis, and mosaic pattern. The radiological features were
correlated with lung function. In 33 patients in which the CT study was extended to
the pancreas, we assessed the degree of pancreatic fatty replacement and correlated
it with functional status.
15 patients had a normal HRCT study (28.8%). The other 37 patients had lesions
with very different severity. Bronchiectasis with mucous plugs were present in
all patients; the disease had a symmetrical distribution in 29/37 patients; in
11/37 patients the upper lung was more severely affected. Correlation between
radiological score and functional tests (FEV1) resulted statistically signiﬁcant
(p< 0.01; r = 0.87). In 19/33 patients (57.6%) a fatty replacement of the pancreas
was observed; it was partial in 11 cases and total in 8; only 4 patients with total
fatty replacement showed exocrine pancreatic dysfunction.
Conclusion: At HRCT severity of pulmonary involvement in patients with CF
diagnosed in adulthood is extremely variable. While the exocrine function is still
normal, CT can detect structural abnormalities of the pancreas suggesting that it is
not too late to consider the diagnosis of CF.
